NCT01050829 - Gadobutrol Magnevist-controlled Body Study | Biotech Hunter

Enrollment

370

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Magnetic Resonance Imaging

Interventions

DRUG

Gadobutrol (Gadovist, BAY86-4875)

Single administration at a dose of 0.1 mmol/kg

DRUG

Gadopentetate Dimeglumine (Magnevist, BAY86-4882)

Single administration at a dose of 0.1 mmol/kg

Trial Locations (15)

100853

Beijing

200032

Shanghai

200233

Shanghai

210009

Nanjing

215006

Suzhou

710032

Xi’an

296-0041

Kamogawa

791-0280

Matsuyama

818-8516

Chikushino-shi

812-0033

Fukuoka

650-0047

Kobe

411-8777

Sunto

113-8431

Bunkyo-ku

150-713

Seoul

158-710

Seoul